日韩av大片在线观看欧美成人不卡|午夜先锋看片|中国女人18毛片水多|免费xx高潮喷水|国产大片美女av|丰满老熟妇好大bbbbbbbbbbb|人妻上司四区|japanese人妻少妇乱中文|少妇做爰喷水高潮受不了|美女人妻被颜射的视频,亚洲国产精品久久艾草一,俄罗斯6一一11萝裸体自慰,午夜三级理论在线观看无码

深圳遠(yuǎn)揚化學(xué)技術(shù)有限公司
中級會員 | 第10年

15012456311

替格瑞洛雜質(zhì)對照品

參   考   價: ￥ 100

訂  貨  量: ≥1 

具體成交價以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品       牌其他品牌

廠商性質(zhì)生產(chǎn)商

所  在  地深圳市

更新時間：2016-04-29 16:36:09瀏覽次數(shù)：1701次

聯(lián)系我時,，請告知來自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
替格瑞洛雜質(zhì)對照品
提供NMR,，HPLC,，MS圖譜及COA證書,，新藥申報可用
Ticagrelor Impurity
全部雜質(zhì)現(xiàn)貨供應(yīng),，*,，并可接受定制,。

替格瑞洛雜質(zhì)對照品   產(chǎn)品介紹：
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選,。
用途：實驗研發(fā),，藥品申報檢測，不得用于臨床醫(yī)學(xué)診斷,。
隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC,，NMR，MS圖譜及CoA證書,。

 

國產(chǎn)進口品牌皆有銷售,，產(chǎn)品庫時常會有更新,，另外,，我司有專業(yè)研發(fā)團隊，可提供部分雜質(zhì)定制服務(wù),，以zui大可能的滿足您雜質(zhì)對照品的選購需求,。

 

替格瑞洛雜質(zhì)對照品    雜質(zhì)列表：

Ticagrelor(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 1(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 2(1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 3(1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 4（Mixture of Diastereomers）(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 5（Mixture of Diastereomers）(1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 62-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
Ticagrelor Impurity 7(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 8(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 92-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 105-amino-6-chloro-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 112-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 12(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 135-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 14(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 15(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 162-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 17(1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 18(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 19(1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 20(1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Ticagrelor Impurity 21(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 22(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 23sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate
Ticagrelor Impurity 24(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 25(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 262-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 27(1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 287-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Ticagrelor Impurity 29(1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol
Ticagrelor Impurity 302-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

 

   除自主雜質(zhì)對照品品牌外,，我司優(yōu)勢代理多個進口雜質(zhì)品牌:EP，USP,，JP,，LGC,TRC，TLC,，Molcan等,，*滿足您對雜質(zhì)對照品的需求。另代理意大利Chromogenix肝素檢測試劑,，英國NIBSC標(biāo)準(zhǔn)試劑,，Sigma-Aldrich試劑, 美國ChromaDex中草藥標(biāo)準(zhǔn)品，瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品,，法國Extrasynthese中草藥標(biāo)準(zhǔn)品,，WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品，NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,，IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,，CIL美國劍橋同位素標(biāo)準(zhǔn)品，種類齊全,，到貨迅速,。

 

     英國NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：

10/175               Reteplase Reference Material

13/322               Polio Anti Sabin type 105 (inactivated) Serum

95/596               Interleukin-57 (Human, rDNA derived)

01/509               Meningococcal serogroup W polysaccharide

13/239               Polio Anti Sabin type 22 (inactivated) Serum

07/300               BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent)

13/249               C-Peptide, Human. 104st International Standard.

95/571               Interleukin-32 (Human, rDNA derived)

95/602               Interleukin-63 (Human, rDNA derived)

10/173               Reteplase Reference Material

10/127               Reteplase Reference Material

01/461               Meningococcal serogroup W polysaccharide

13/294               Polio Anti Sabin type 77 (inactivated) Serum

13/233               C-Peptide, Human. 88st International Standard.

95/572               Interleukin-33 (Human, rDNA derived)

03/104-079         HTLV-64 (antibody) Monitor Sample

13/144               Influenza Antigen B/Massachusetts/02/2022 (Egg derived)

13/180               Influenza Antigen B/Massachusetts/02/2058 (Egg derived)

01/528               Meningococcal serogroup W polysaccharide

13/178               C-Peptide, Human. 33st International Standard.

07/373               BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)

07/324               BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)

13/241               C-Peptide, Human. 96st International Standard.

07/290               BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)

03/104-061         HTLV-46 (antibody) Monitor Sample

07/358               BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)

10/185               Reteplase Reference Material

07/364               BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)

03/104-056         HTLV-41 (antibody) Monitor Sample

13/146               C-Peptide, Human. 1st International Standard.

12/B623-083       QCRFLUAH1N1QC1-Influenza AH1N1 QC81

10/158               Reteplase Reference Material

13/229               C-Peptide, Human. 84st International Standard.

01/428               Meningococcal serogroup W polysaccharide

01/449               Meningococcal serogroup W polysaccharide

13/236               Influenza Antigen B/Massachusetts/02/2114 (Egg derived)

13/233               Influenza Antigen B/Massachusetts/02/2111 (Egg derived)

07/359               BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)

 

更多關(guān)于    的產(chǎn)品信息，請我司。

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏！
標(biāo)簽：
保存成功

(空格分隔,最多3個,單個標(biāo)簽最多10個字符)

常用：

提示

X
您的留言已提交成功,！我們將在第一時間回復(fù)您~
撥打電話
在線留言